DRRX
Price
$0.85
Change
+$0.02 (+2.41%)
Updated
Jan 17 closing price
Capitalization
33.11M
YCBD
Price
$0.50
Change
-$0.06 (-10.71%)
Updated
Jan 17 closing price
Capitalization
2.62M
Ad is loading...

DRRX vs YCBD

Header iconDRRX vs YCBD Comparison
Open Charts DRRX vs YCBDBanner chart's image
DURECT
Price$0.85
Change+$0.02 (+2.41%)
Volume$30.62K
Capitalization33.11M
cbdMD
Price$0.50
Change-$0.06 (-10.71%)
Volume$1.52M
Capitalization2.62M
DRRX vs YCBD Comparison Chart
Loading...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DRRX vs. YCBD commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DRRX is a Hold and YCBD is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (DRRX: $0.85 vs. YCBD: $0.50)
Brand notoriety: DRRX and YCBD are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: DRRX: 24% vs. YCBD: 84%
Market capitalization -- DRRX: $33.11M vs. YCBD: $2.62M
DRRX [@Pharmaceuticals: Other] is valued at $33.11M. YCBD’s [@Pharmaceuticals: Other] market capitalization is $2.62M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DRRX’s FA Score shows that 0 FA rating(s) are green whileYCBD’s FA Score has 0 green FA rating(s).

  • DRRX’s FA Score: 0 green, 5 red.
  • YCBD’s FA Score: 0 green, 5 red.
According to our system of comparison, YCBD is a better buy in the long-term than DRRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DRRX’s TA Score shows that 2 TA indicator(s) are bullish while YCBD’s TA Score has 4 bullish TA indicator(s).

  • DRRX’s TA Score: 2 bullish, 3 bearish.
  • YCBD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, YCBD is a better buy in the short-term than DRRX.

Price Growth

DRRX (@Pharmaceuticals: Other) experienced а +10.23% price change this week, while YCBD (@Pharmaceuticals: Other) price change was -10.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Reported Earning Dates

DRRX is expected to report earnings on May 09, 2023.

YCBD is expected to report earnings on Aug 10, 2023.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DRRX($33.1M) has a higher market cap than YCBD($2.62M). YCBD YTD gains are higher at: 33.973 vs. DRRX (13.320). YCBD has higher annual earnings (EBITDA): -3.44M vs. DRRX (-33.66M). DRRX has more cash in the bank: 39M vs. YCBD (1.51M). YCBD has less debt than DRRX: YCBD (3.37M) vs DRRX (23.2M). YCBD has higher revenues than DRRX: YCBD (23.4M) vs DRRX (9.19M).
DRRXYCBDDRRX / YCBD
Capitalization33.1M2.62M1,264%
EBITDA-33.66M-3.44M978%
Gain YTD13.32033.97339%
P/E RatioN/A0.00-
Revenue9.19M23.4M39%
Total Cash39M1.51M2,591%
Total Debt23.2M3.37M689%
FUNDAMENTALS RATINGS
DRRX vs YCBD: Fundamental Ratings
DRRX
YCBD
OUTLOOK RATING
1..100
956
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9999
PRICE GROWTH RATING
1..100
6449
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

YCBD's Valuation (53) in the Other Consumer Services industry is in the same range as DRRX (84) in the Pharmaceuticals Other industry. This means that YCBD’s stock grew similarly to DRRX’s over the last 12 months.

YCBD's Profit vs Risk Rating (100) in the Other Consumer Services industry is in the same range as DRRX (100) in the Pharmaceuticals Other industry. This means that YCBD’s stock grew similarly to DRRX’s over the last 12 months.

YCBD's SMR Rating (99) in the Other Consumer Services industry is in the same range as DRRX (99) in the Pharmaceuticals Other industry. This means that YCBD’s stock grew similarly to DRRX’s over the last 12 months.

YCBD's Price Growth Rating (49) in the Other Consumer Services industry is in the same range as DRRX (64) in the Pharmaceuticals Other industry. This means that YCBD’s stock grew similarly to DRRX’s over the last 12 months.

YCBD's P/E Growth Rating (66) in the Other Consumer Services industry is somewhat better than the same rating for DRRX (100) in the Pharmaceuticals Other industry. This means that YCBD’s stock grew somewhat faster than DRRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DRRXYCBD
RSI
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 12 days ago
83%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bearish Trend 12 days ago
89%
Bullish Trend 12 days ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
80%
Bullish Trend 12 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
82%
Advances
ODDS (%)
Bullish Trend 17 days ago
81%
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 20 days ago
88%
Bearish Trend 12 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
Aroon
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
DRRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
YCBD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLUT263.105.54
+2.15%
Flutter Entertainment plc
PLXS167.362.42
+1.47%
Plexus Corp
NGD2.75N/A
N/A
New Gold
IPI26.51-0.23
-0.86%
Intrepid Potash
CVKD17.40-0.80
-4.40%
Cadrenal Therapeutics Inc

DRRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, DRRX has been loosely correlated with ANIP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DRRX jumps, then ANIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DRRX
1D Price
Change %
DRRX100%
+2.15%
ANIP - DRRX
38%
Loosely correlated
+1.67%
UPC - DRRX
27%
Poorly correlated
+4.40%
SNDL - DRRX
24%
Poorly correlated
-1.11%
OGI - DRRX
22%
Poorly correlated
-1.27%
ACB - DRRX
22%
Poorly correlated
-2.78%
More

YCBD and

Correlation & Price change

A.I.dvisor tells us that YCBD and CGC have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that YCBD and CGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To YCBD
1D Price
Change %
YCBD100%
-10.38%
CGC - YCBD
28%
Poorly correlated
-3.11%
RGEDF - YCBD
28%
Poorly correlated
N/A
ACB - YCBD
23%
Poorly correlated
-2.78%
DRRX - YCBD
23%
Poorly correlated
+2.15%
SXTC - YCBD
23%
Poorly correlated
+0.10%
More